PCV75 - AN UPDATED COST-EFFECTIVENESS PAIRWISE ANALYSIS OF APIXABAN AND WARFARIN FOR STROKE PREVENTION IN PATIENTS WITH NON- VALVULAR ATRIAL FIBRILLATION IN FRANCE

Autor:	F. Maunoury, T. Prawitz, Anne-Françoise Gaudin, T. Lanitis, B. Bregman, François-Emery Cotté
Rok vydání:	2018
Předmět:	medicine.medical_specialty Cost effectiveness business.industry Health Policy Public Health Environmental and Occupational Health Non valvular atrial fibrillation Warfarin Internal medicine Stroke prevention medicine Cardiology In patient Pairwise comparison Apixaban business medicine.drug
Zdroj:	Value in Health. 21:S105
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c381c9eb6da22be6e636183646d83e7f https://doi.org/10.1016/j.jval.2018.09.621 Zobrazit plný text záznamu Full Text from ScienceDirect